Next Article in Journal
Radiotracers for the Central Serotoninergic System
Next Article in Special Issue
Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
Previous Article in Journal
Significant Sex Differences in the Efficacy of the CSF1R Inhibitor-PLX5622 on Rat Brain Microglia Elimination
Previous Article in Special Issue
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(5), 570; https://doi.org/10.3390/ph15050570
Action Date Notes Link
article pdf uploaded. 2 May 2022 13:21 CEST Version of Record https://www.mdpi.com/1424-8247/15/5/570/pdf-vor
article supplementary file uploaded. 10 May 2022 04:45 CEST - https://www.mdpi.com/1424-8247/15/5/570#supplementary
article xml file uploaded 10 May 2022 05:42 CEST Original file -
article xml uploaded. 10 May 2022 05:42 CEST Update https://www.mdpi.com/1424-8247/15/5/570/xml
article pdf uploaded. 10 May 2022 05:42 CEST Updated version of record https://www.mdpi.com/1424-8247/15/5/570/pdf
article html file updated 10 May 2022 05:43 CEST Original file -
article html file updated 2 August 2022 21:59 CEST Update https://www.mdpi.com/1424-8247/15/5/570/html
Back to TopTop